Strides Shasun gains on receiving EIR for R&D Centre in Chennai

05 Dec 2016 Evaluate

Strides Shasun is currently trading at Rs. 1078.00, up by 2.40 points or 0.22% from its previous closing of Rs. 1075.60 on the BSE.

The scrip opened at Rs. 1075.00 and has touched a high and low of Rs. 1101.35 and Rs. 1064.00 respectively. So far 24,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1400.00 on 10-Dec-2015 and a 52 week low of Rs. 848.00 on 29-Feb-2016.

Last one week high and low of the scrip stood at Rs. 1102.50 and Rs. 1064.00 respectively. The current market cap of the company is Rs. 9,633.95 crore.

The promoters holding in the company stood at 31.14%, while Institutions and Non-Institutions held 47.91% and 20.95% respectively.

Strides Shasun’s control test laboratory, which is part of its R&D Centre in Chennai was inspected by the U.S. Food and Drug Administration (USFDA) in August 2016 has received the Establishment Inspection Report (EIR), thereby confirming the closure of the inspection. The laboratory continues to be USFDA approved.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and and semi-solids.


Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×